$1.47 Billion is the total value of Chicago Capital, LLC's 211 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TRU | New | TRANSUNION | $18,666,000 | – | 279,264 | +100.0% | 1.27% | – |
SIVB | New | SVB FINANCIAL GROUP | $13,507,000 | – | 60,745 | +100.0% | 0.92% | – |
FITB | New | FIFTH THIRD BANCORP | $1,021,000 | – | 40,469 | +100.0% | 0.07% | – |
TDG | New | TRANSDIGM GROUP INC | $681,000 | – | 1,500 | +100.0% | 0.05% | – |
SBRCY | New | SBERBANK OF RUSSIA PJSCordinary | $671,000 | – | 50,600 | +100.0% | 0.05% | – |
APH | New | AMPHENOL CORPclass a | $529,000 | – | 5,600 | +100.0% | 0.04% | – |
CHKP | New | CHECK POINT SOFTWARE TECHNOLOGIES LTDordinary | $392,000 | – | 3,100 | +100.0% | 0.03% | – |
GIS | New | GENERAL MILLS INC | $389,000 | – | 7,512 | +100.0% | 0.03% | – |
YUMC | New | YUM CHINA HLDGS INC COMgu | $351,000 | – | 7,807 | +100.0% | 0.02% | – |
GILD | New | GILEAD SCIENCES INC | $278,000 | – | 4,272 | +100.0% | 0.02% | – |
GSK | New | GLAXOSMITHKLINE PLC ADRordinary | $270,000 | – | 6,469 | +100.0% | 0.02% | – |
RTN | New | RAYTHEON CO COM NEW | $244,000 | – | 1,342 | +100.0% | 0.02% | – |
IQV | New | IQVIA HLDGS INC | $245,000 | – | 1,700 | +100.0% | 0.02% | – |
NSC | New | NORFOLK SOUTHERN CRP | $243,000 | – | 1,300 | +100.0% | 0.02% | – |
RHT | New | RED HAT INC | $231,000 | – | 1,263 | +100.0% | 0.02% | – |
EEM | New | ISHARES INCishares msci emerging markets | $218,000 | – | 5,080 | +100.0% | 0.02% | – |
TEAM | New | ATLASSIAN CORPORATION PLCclass a | $225,000 | – | 2,000 | +100.0% | 0.02% | – |
ACN | New | ACCENTURE PLC Aclass a | $227,000 | – | 1,292 | +100.0% | 0.02% | – |
IP | New | INTERNATIONAL PAPER CO | $204,000 | – | 4,400 | +100.0% | 0.01% | – |
BE | New | BLOOM ENERGY CORP CL Aclass a | $150,000 | – | 11,642 | +100.0% | 0.01% | – |
New | PORTFOLIO RECOVERY ASSOCS INnote 3.000% 8/0 | $79,000 | – | 82,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-04-23
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VISA INC CL A | 23 | Q3 2023 | 4.2% |
APPLE INC | 23 | Q3 2023 | 4.1% |
INTERCONTINENTAL EXCHANGE INC | 23 | Q3 2023 | 3.6% |
PROGRESSIVE CORP OHIO | 23 | Q3 2023 | 3.5% |
ALPHABET INC CAP STK CL A | 23 | Q3 2023 | 3.7% |
DEXCOM INC | 23 | Q3 2023 | 3.9% |
AMAZONCOM INC | 23 | Q3 2023 | 3.2% |
LOWES COS INC | 23 | Q3 2023 | 3.6% |
FAIR ISAAC CORP | 23 | Q3 2023 | 3.8% |
COSTAR GROUP INC | 23 | Q3 2023 | 3.7% |
View Chicago Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ALBIREO PHARMA, INC. | January 23, 2023 | 1,362,484 | 6.6% |
DYNAVAX TECHNOLOGIES CORP | March 04, 2022 | 573,403,369 | 4.3% |
DYNAVAX TECHNOLOGIES CORP | February 23, 2021 | ? | ? |
View Chicago Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-15 |
SC 13G | 2024-03-04 |
13F-HR | 2024-01-22 |
13F-HR | 2023-10-25 |
13F-HR | 2023-07-20 |
13F-HR | 2023-04-18 |
SC 13G | 2023-01-23 |
13F-HR | 2023-01-20 |
13F-HR | 2022-10-14 |
13F-HR | 2022-07-21 |
View Chicago Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.